Hematuria in adults

JR Ingelfinger - New England journal of medicine, 2021 - Mass Medical Soc
Assessment of Patients with Hematuria Hematuria comes in two main varieties: gross and
microscopic. A wide range of ailments can lead to hematuria, and the central task is to rule …

Molecular markers for bladder cancer screening: an insight into bladder cancer and FDA-approved biomarkers

GV Flores Monar, T Reynolds, M Gordon… - International Journal of …, 2023 - mdpi.com
Bladder cancer is one of the most financially burdensome cancers globally, from its
diagnostic to its terminal stages. The impact it imposes on patients and the medical …

Prognostic risk model and tumor immune environment modulation of m5C-related LncRNAs in pancreatic ductal adenocarcinoma

H Yuan, J Liu, L Zhao, P Wu, G Chen, Q Chen… - Frontiers in …, 2021 - frontiersin.org
RNA methylation modification is a key process in epigenetics that regulates
posttranscriptional gene expression. With advances in next-generation sequencing …

Identification of a novel ferroptosis-related gene prognostic signature in bladder cancer

J Sun, W Yue, J You, X Wei, Y Huang, Z Ling… - Frontiers in …, 2021 - frontiersin.org
Background Ferroptosis is a newly found non-apoptotic forms of cell death that plays an
important role in tumors. However, the prognostic value of ferroptosis-related genes (FRG) in …

Naturally-occurring invasive urothelial carcinoma in dogs, a unique model to drive advances in managing muscle invasive bladder cancer in humans

DW Knapp, D Dhawan, JA Ramos-Vara… - Frontiers in …, 2020 - frontiersin.org
There is a great need to improve the outlook for people facing urinary bladder cancer,
especially for patients with invasive urothelial carcinoma (InvUC) which is lethal in 50% of …

Application of nanotechnology in bladder cancer diagnosis and therapeutic drug delivery

H Li, J Zhu, G Weng, J Li, L Li, J Zhao - Journal of Materials Chemistry …, 2023 - pubs.rsc.org
Bladder cancer (BC) is one of the most common malignant tumors in the urinary system, and
its high recurrence rate causes a great economic burden to patients. Traditional diagnosis …

Deep learning–based recurrence prediction in patients with non–muscle-invasive bladder cancer

M Lucas, I Jansen, TG van Leeuwen, JR Oddens… - European urology …, 2022 - Elsevier
Background Non–muscle-invasive bladder cancer (NMIBC) is characterized by frequent
recurrence of the disease, which is difficult to predict. Objective To combine digital …

The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy

S Zhang, J Du, X Zhong, P Tan, H Xu, J Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Biomarkers acquired from blood samples are easy to obtain and cost-effective,
have attracted considerable interest, and have been widely investigated. Inflammation plays …

Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer

S Katayama, K Mori, B Pradere, E Laukhtina… - World Journal of …, 2021 - Springer
Purpose We assessed the prognostic value of systemic immune-inflammation index (SII) to
refine risk stratification of the heterogeneous spectrum of patients with non-muscle-invasive …

MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder

L Zhu, X Liu, W Zhang, H Hu, Q Wang, K Xu - BMC cancer, 2022 - Springer
Background The bifunctional methylenetetrahydrofolate dehydrogenase (NADP+
dependent) 2, methenyltetrahydrofolate cyclohydrolase (MTHFD2) has been reported to …